| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 373.10K | 409.41K | 668.82K | 375.73K | 621.57K | 398.45K |
| Gross Profit | 261.17K | 409.41K | 197.38K | 97.07K | 329.94K | 253.95K |
| EBITDA | -336.76K | -338.30K | -182.56K | -52.12K | 2.72M | 202.59K |
| Net Income | -335.58K | -337.32K | -182.99K | -425.52K | 2.56M | 245.89K |
Balance Sheet | ||||||
| Total Assets | 3.19M | 3.18M | 3.43M | 3.35M | 3.73M | 796.97K |
| Cash, Cash Equivalents and Short-Term Investments | 3.04M | 3.02M | 3.29M | 3.15M | 3.54M | 656.36K |
| Total Debt | 7.50K | 2.50K | 22.50K | 32.50K | 42.50K | 50.00K |
| Total Liabilities | 123.20K | 145.99K | 84.53K | 124.06K | 99.87K | 111.21K |
| Stockholders Equity | 3.06M | 3.04M | 3.35M | 3.23M | 3.63M | 685.75K |
Cash Flow | ||||||
| Free Cash Flow | -57.79K | -185.71K | -256.06K | -367.22K | -131.85K | -92.51K |
| Operating Cash Flow | -238.85K | -185.71K | -256.06K | -367.22K | -131.85K | -191.79K |
| Investing Cash Flow | 50.00K | 160.08K | -3.64K | 226.93K | -42.46K | -49.65K |
| Financing Cash Flow | 192.50K | -10.41K | 225.10K | -8.42K | 355.00K | 317.49K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | £3.58M | ― | 66.17% | 26.13% | ― | ― | |
60 Neutral | £41.17M | 25.58 | 3.69% | 7.96% | -9.55% | ― | |
58 Neutral | £133.58M | 26.47 | 4.84% | ― | 15.42% | ― | |
56 Neutral | £14.55M | 2.58 | 14.69% | 2.12% | -17.37% | ― | |
50 Neutral | £2.75M | -7.67 | -10.57% | ― | -57.15% | -77.78% | |
48 Neutral | £9.90M | ― | ― | ― | ― | ― |
Marechale Capital reported a weaker first half for the six months to 31 October 2025, with revenue falling to £111,932 and gross profit halving to £55,310, resulting in an operating loss of £177,066 and a loss before tax of £176,515. Net asset value declined modestly to £3.06m, or 2.56p per share, though the balance sheet remains underpinned by its investment portfolio, notably Weardale Lithium, and cash at bank increased after period-end to £312,000 on the back of recently completed transactions. While advisory project delays weighed on performance, the firm has recently executed debt and equity growth financings for clients including Wright Brothers, KBH, Weardale Lithium and Chestnut Inns, and completed an October share placing that brought in two new strategic investors alongside director participation. The board highlights a strengthening pipeline, improving sentiment in the UK SME and growth company market, and is pursuing additional strategic partnerships and funding relationships to enhance shareholder value and capitalise on opportunities in its core sectors despite the challenging economic climate.
The most recent analyst rating on (GB:MAC) stock is a Hold with a £2.50 price target. To see the full list of analyst forecasts on Marechale Capital stock, see the GB:MAC Stock Forecast page.